KALA BIO, Inc.

KALA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2020

Total Assets: $221.6M

Liabilities Breakdown FY2020

Total Liabilities: $121.6M